8 patents
Utility
Artificial Immunosurveillance Chimeric Antigen Receptor and Cells Expressing the Same
2 Nov 23
A non-viral vector, comprising, from 5′ to 3′, flanked by two transposon terminal inverted repeats, an inducible promoter, a first coding region comprising a specific combination of genes whose expression is localized to a tumor microenviorment and their function being mediators of CAR persistence and anti-tumor mechanisms to stimulate or enhance a patient anti-tumor response; a second promoter and coding region for expressing one or more artificial immunosurveillance chimeric antigen receptors (AI-CAR), and a truncated CD20 or truncated EGFR safety target.
Donald E. Staunton, John M. Luk, John M. Harlan, David Kin Jin
Filed: 21 Feb 20
Utility
Qty FC Fusion Receptor Proteins
20 Apr 23
The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
Filed: 29 Jul 22
Utility
QTY FC fusion water soluble receptor proteins
17 Jan 23
The present invention is directed to QTY Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
David Jin, Rui Qing, Shuguang Zhang
Filed: 24 Mar 21
Utility
QTY FC fusion receptor proteins
2 Aug 22
The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
Filed: 24 Mar 21
Utility
Emulsomes Comprising S-layer Fusion Proteins and Methods of Use Thereof
3 Feb 22
The invention encompasses emulsomes coated with S-layer fusion proteins, pharmaceutical compositions and vaccines comprising the emulsomes, and methods of use thereof for immunizing a patient.
Uwe Sleytr, David Jin
Filed: 22 Jun 21
Utility
S-layer Vaccine Fusion Proteins and Methods of Use
30 Dec 21
Described are S-layer fusion proteins comprising a self-assembling domain of a S-layer protein and a viral spike protein or a fragment thereof, a pharmaceutical composition (such as a vaccine) comprising the S-layer fusion protein, and method of immunizing a patient in need thereof comprising administering the vaccine.
Uwe Sleytr, David Jin
Filed: 22 Jun 21
Utility
QTY FC Fusion Receptor Proteins
7 Oct 21
The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
Filed: 24 Mar 21
Utility
Qty FC Fusion Water Soluble Receptor Proteins
30 Sep 21
The present invention is directed to QTY Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
David Jin, Rui Qing, Shuguang Zhang
Filed: 24 Mar 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first